BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6485183)

  • 1. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
    Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
    Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of circulating immune complexes by polyethyleneglycol precipitations complement consumption test in urological malignant diseases].
    Sakai S; Kato N; Ito Y; Matsuda S; Koide T; Deguti T; Kuriyama M; Ban Y; Nishiura T; Tei K
    Hinyokika Kiyo; 1984 Nov; 30(11):1611-7. PubMed ID: 6543290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in pulmonary tuberculosis.
    Ashtekar MD; Samuel AM
    J Clin Lab Immunol; 1985 Oct; 18(2):91-5. PubMed ID: 3935794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of circulating immune complexes in cancer patients.
    Dass TK; Aziz M; Rattan A
    Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
    Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
    Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence and structure of circulating immune complexes in patients with prostate tumors.
    Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
    Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating immune complexes in cutaneous diseases associated with immune disorders.
    Fernández Bussy R; Crisci CD; Fiorenza G; Bertoya N
    Allergol Immunopathol (Madr); 1990; 18(1):47-52. PubMed ID: 2143349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
    Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
    Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
    Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
    Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.